Rhythm Pharmaceuticals, Inc. (RYTM)

NASDAQ: RYTM · Real-Time Price · USD

99.61

+0.78 (0.79%)

Sep 22, 2026, 3:17 PM EDT - Market open

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Product Revenue, Net	239.92M	194.77M	130.13M
License Revenue	-	-5.01M	-
Revenue (Total)	239.92M	189.76M	130.13M

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
License Revenue	-	-5.01M	-
United States Revenue	165.08M	133.55M	96.11M
International Revenue	-	-	34.02M
Revenue (Other)	74.84M	61.22M	-
Revenue (Total)	239.92M	189.76M	130.13M